Skip to main content
. 2011 Jul 14;2:75–84. doi: 10.2147/OAJSM.S17048

Figure 4.

Figure 4

Overall tolerability of diclofenac epolamine topical patch (DETP) or placebo for each treatment group, assessed by patients and investigators at day 7 for Study 1 A) and Study 2 B). The majority of patients in both treatment groups judged the patch tolerability as excellent. No significant differences were found between DETP- and placebo-treated patients at day 7; results from day 3 tolerability assessments were comparable (not shown).